Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.
about
International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantationThe myeloma stem cell concept, revisited: from phenomenology to operational termsEvaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myelomaThe European Hematology Association Roadmap for European Hematology Research: a consensus documentAdvances in understanding prognosis in myeloma.Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group.Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myelomaGenome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience.Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myelomaChromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapiesCombined DNA-RNA fluorescent in situ hybridization (FISH) to study X chromosome inactivation in differentiated female mouse embryonic stem cellsGlobal myeloma research clusters, output, and citations: a bibliometric mapping and clustering analysisA molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myelomaHeterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma.Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System.Multiple Myeloma: Treatment is Getting IndividualizedDetection of recurrent cytogenetic aberrations in multiple myeloma: a comparison between MLPA and iFISH.MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma.Genetic aberrations in multiple myeloma characterized by cIg-FISH: a Brazilian context.Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in OncologyImpact of genetic abnormalities on the prognoses and clinical parameters of patients with multiple myeloma.Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group.Target fluorescence in-situ hybridization (Target FISH) for plasma cell enrichment in myeloma.Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma.N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma.Genomic profiling of plasma cell disorders in a clinical setting: integration of microarray and FISH, after CD138 selection of bone marrow.Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prognostic value.Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India.Is there a role for allogeneic transplantation in chronic myeloid leukemia?Optimal management of elderly patients with myeloma.Maintenance therapy in newly diagnosed multiple myeloma: current recommendations.Cancer cytogenetics: methodology revisited.Genetics in myeloma: genetic technologies and their application to screening approaches in myeloma.Validation of break-apart and fusion MYC probes using a digital fluorescence in situ hybridization capture and imaging system.Quantitative PCR: an alternative approach to detect common copy number alterations in multiple myeloma.Combination of t(4;14), del(17p13), del(1p32) and 1q21 gain FISH probes identifies clonal heterogeneity and enhances the detection of adverse cytogenetic profiles in 233 newly diagnosed multiple myeloma.A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients.High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma.Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience.
P2860
Q27002668-5A34DD64-9185-48E3-A0A9-4329CD7A8467Q28076070-DC954801-65BF-44AA-A40F-E3B5811BFBDDQ28296718-24BF53BB-AAEA-4316-BBE3-07CE7AB86964Q28830861-5004620E-A50A-4EAA-A2D9-AAC63B6FF52AQ30244061-0FD2F636-B7CD-41BE-8AF1-B98C0BC83E9AQ31154933-2C4D9D86-4B06-45C6-A4E3-6AE3EDC7EE76Q33573752-5EA1F382-44F5-45DE-B580-F114C9B2E4E6Q33768000-3D9691F9-F6EF-450B-B7D6-05D8EC49325FQ33816012-A18074AF-E78C-4CCC-930B-466A39FA89B4Q34272540-98E39759-AA42-4262-9C8A-B3E9F774BF86Q34305860-D5BDA0F3-874A-4582-B31E-718AA0363872Q35023376-66258869-D5C7-4A76-8AF6-23D51C7F59A8Q35025456-B4865B9D-5307-4762-B421-5916FEAF9F0CQ35832389-8FD77F06-5019-4232-B9F9-C9C8D6A76889Q36193181-8AA26E66-4A06-4B4F-BEAF-9BE2CDDA478DQ36522964-F2E8E751-998A-4CD9-9962-69095EC17813Q36544069-DB19F2DE-1AA8-44C1-948F-434C6A89941FQ36546019-4F406494-9286-41F0-8A3B-A49B3EB6B472Q36793582-766E2289-FCC7-42C2-885A-1A97A80F246AQ36839385-D2C79B80-AAC7-46F4-9113-E6435D863152Q36963203-2F510D59-F947-4C4B-9469-64B64C52365BQ36973054-38BBD185-BCE4-43B0-A685-351E2AFE55B5Q37037265-0688EF81-C3F4-4E1A-9CB4-A241E2AF9C72Q37178643-FA557C1A-8708-4A2C-A72C-B801D5294CA7Q37328415-694691B0-75D4-47EB-A31D-D949C87C8DAAQ37456396-EA506562-B379-4F18-9672-33B1BCF2676CQ37465362-8E57A604-9048-48BE-8979-4BE0967A126FQ37552056-2F12B7E6-EE26-4E0C-8D62-DCAC0D54E9CCQ37692687-4F8591E3-6D1B-402D-9DA9-0EEAB1BCCE07Q38161964-52A04822-A5F4-4AB5-A602-7F28DFDD30D6Q38168925-B8882026-DCF3-4A83-B7B9-72D184FB5E4EQ38191975-1161BA16-B185-43B3-8E89-FACB30B4A662Q38264921-757B15EC-A264-4487-A11D-CCE9949AC330Q38348173-62CD3B5B-8548-4E7A-B4D0-E75E4857DCFAQ38380157-F1E6EBC0-BC30-46CF-82AC-D91C67CF7A1DQ38645307-12490FC0-69A7-4B59-B708-6A502753E893Q38662337-E5ED02B6-0083-4830-B308-7AF4AC85D2DEQ38762572-0237F152-B2B4-4A41-ADA5-CE253C3D996AQ38832538-A9F119E5-6AD6-4AAF-8E98-802348B833BBQ38915277-A5DCD1B0-B490-471A-991D-A1667FAA3401
P2860
Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Report from the European Myelo ...... myeloma and related disorders.
@ast
Report from the European Myelo ...... myeloma and related disorders.
@en
type
label
Report from the European Myelo ...... myeloma and related disorders.
@ast
Report from the European Myelo ...... myeloma and related disorders.
@en
prefLabel
Report from the European Myelo ...... myeloma and related disorders.
@ast
Report from the European Myelo ...... myeloma and related disorders.
@en
P2093
P2860
P50
P1433
P1476
Report from the European Myelo ...... myeloma and related disorders.
@en
P2093
Adele M Testi
Alberto Rocci
Anna Collin
Brigitte Maes
Clare Hodkinson
Dariusz Ladon
European Myeloma Network
Fiona M Ross
Geneviève Ameye
Gitte Kerndrup
P2860
P304
P356
10.3324/HAEMATOL.2011.056176
P50
P577
2012-02-27T00:00:00Z